Lin Ye Selected Research

Glucose (Dextrose)

1/2021	MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4.
1/2021	Exosomal circEhmt1 Released from Hypoxia-Pretreated Pericytes Regulates High Glucose-Induced Microvascular Dysfunction via the NFIA/NLRP3 Pathway.
4/2020	Knockdown of MALAT1 attenuates high-glucose-induced angiogenesis and inflammation via endoplasmic reticulum stress in human retinal vascular endothelial cells.
1/2016	The Effect of Hippocampal Cognitive Impairment and XIAP on Glucose and Lipids Metabolism in Rats.
8/2015	Protective effects of extendin‑4 on hypoxia/reoxygenation‑induced injury in H9c2 cells.
5/2015	Locally controlled delivery of TNFα antibody from a novel glucose-sensitive scaffold enhances alveolar bone healing in diabetic conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Ye Research Topics

Disease

136	Neoplasms (Cancer) 04/2024 - 02/2007
51	Neoplasm Metastasis (Metastasis) 05/2023 - 02/2007
36	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2007
35	Breast Neoplasms (Breast Cancer) 08/2023 - 08/2003
26	Inflammation (Inflammations) 04/2024 - 05/2015
16	Stomach Neoplasms (Stomach Cancer) 12/2023 - 11/2012
16	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 01/2009
15	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2008
14	Carcinogenesis 06/2023 - 10/2010
12	Wounds and Injuries (Trauma) 02/2024 - 11/2010
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2010
10	Carcinoma (Carcinomatosis) 03/2024 - 04/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 03/2016
9	Disease Progression 07/2023 - 01/2017
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2013
8	Infections 04/2024 - 07/2014
8	Fibrosis (Cirrhosis) 09/2023 - 12/2015
8	Obesity 01/2023 - 08/2011
8	Body Weight (Weight, Body) 01/2022 - 07/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 09/2008
7	COVID-19 05/2024 - 11/2020
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2012
6	Necrosis 04/2024 - 07/2009
6	Non-alcoholic Fatty Liver Disease 02/2023 - 06/2016
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 10/2019
5	Stroke (Strokes) 10/2023 - 03/2011
4	Osteosarcoma (Osteogenic Sarcoma) 11/2023 - 09/2013
4	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 07/2023 - 06/2019
4	Osteoporosis 04/2023 - 10/2021
4	Melanoma (Melanoma, Malignant) 01/2023 - 08/2013
4	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2014
4	Adenocarcinoma 01/2022 - 12/2012
4	Hypoxia (Hypoxemia) 05/2021 - 04/2014
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 12/2011
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 04/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
3	Starvation 10/2022 - 07/2012
3	Hyperplasia 05/2022 - 04/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2019
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 03/2015
3	Colonic Neoplasms (Colon Cancer) 11/2021 - 01/2010
3	Neuroblastoma 09/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

89	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
28	Messenger RNA (mRNA)IBA 01/2022 - 01/2005
22	Biomarkers (Surrogate Marker)IBA 06/2023 - 12/2013
21	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2023 - 02/2007
19	CytokinesIBA 04/2024 - 06/2004
14	LipidsIBA 07/2023 - 01/2016
13	Diethylhexyl Phthalate (DEHP)IBA 07/2023 - 07/2014
13	MicroRNAs (MicroRNA)IBA 11/2022 - 02/2013
11	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2020
10	Catalytic RNA (Ribozymes)IBA 05/2017 - 09/2007
9	Long Noncoding RNAIBA 01/2023 - 01/2018
8	Therapeutic UsesIBA 12/2023 - 11/2005
8	EnzymesIBA 01/2023 - 06/2004
8	Growth InhibitorsIBA 01/2017 - 07/2009
7	yangzheng xiaojiIBA 01/2024 - 07/2012
7	LigandsIBA 10/2022 - 07/2009
7	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2015 - 02/2007
6	HydrogelsIBA 02/2024 - 11/2020
6	phthalic acid (phthalate)IBA 07/2023 - 04/2019
6	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2010
6	CateninsIBA 01/2022 - 06/2017
6	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2009
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2018
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2015
6	S100 Calcium Binding Protein A7IBA 01/2020 - 12/2012
5	Bone Morphogenetic Protein ReceptorsIBA 01/2023 - 02/2007
5	CollagenIBA 10/2022 - 05/2015
5	ImmunosorbentsIBA 12/2021 - 06/2004
5	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 01/2005
5	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 01/2009
4	Retinaldehyde (Retinal)IBA 01/2024 - 04/2020
4	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 09/2014
4	Phosphotransferases (Kinase)IBA 12/2023 - 02/2018
4	CurcuminIBA 09/2023 - 01/2021
4	mono-(2-ethylhexyl)phthalateIBA 07/2023 - 11/2019
4	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2017
4	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 10/2012
4	AutoantibodiesIBA 01/2020 - 07/2010
4	Protein Isoforms (Isoforms)IBA 05/2017 - 01/2011
4	Epidermal Growth Factor (EGF)IBA 03/2017 - 01/2009
4	hammerhead ribozymeIBA 03/2016 - 07/2008
4	Growth Differentiation Factor 9IBA 03/2012 - 11/2010
3	Interleukin-6 (Interleukin 6)IBA 05/2024 - 04/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2019
3	Circular RNAIBA 01/2024 - 03/2021
3	GlucocorticoidsIBA 07/2023 - 07/2020
3	Phenobarbital (Luminal)FDA Link 05/2023 - 01/2018
3	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2023 - 01/2017
3	TransglutaminasesIBA 01/2023 - 08/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 06/2004

Therapy/Procedure

34	Therapeutics 01/2024 - 07/2008
13	Drug Therapy (Chemotherapy) 11/2023 - 02/2010
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023 - 03/2015
5	Immunotherapy 01/2022 - 05/2021
4	Radiotherapy 01/2022 - 12/2013
4	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 06/2014